Wang X, Li Y, Fu G, Xu B, et al. Three-year clinical outcomes of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: A prospective patient-level pooled analysis of NeoVas trials. Catheter Cardiovasc Interv 2023;101:967-972.
PMID: 36881746